Fibroin-derived protein composition

1. A fibroin-derived protein composition that possesses enhanced stability in an aqueous solution, wherein:

the primary amino acid sequences of the fibroin-derived protein composition differ from native fibroin by at least 6% with respect to the combined amino acid content of serine, glycine, and alanine, based on the combined absolute values of the differences in the content of serine, glycine, and alanine;

cysteine disulfide bonds between the fibroin heavy and fibroin light protein chains of fibroin are reduced or eliminated;

the protein composition has a serine content that is reduced by greater than 25% compared to native fibroin protein, and the protein composition comprises between 4.5% and 7.5% serine amino acid residues;

wherein the average molecular weight of the fibroin-derived protein composition is less than about 100 kDa; and

wherein the protein composition has an aqueous viscosity of less than 4 cP as a 10% w/w solution in water.

2. The protein composition of claim 1 wherein the protein composition has an aqueous viscosity of less than 10 cP as a 24% w/w solution in water.

3. The protein composition of claim 1 wherein the protein composition is soluble in water at 40% w/w without precipitation.

4. The protein composition of claim 1 wherein the protein composition does not gel upon ultrasonication of an aqueous solution of the protein composition at concentrations of up to 10% w/w.

5. The protein composition of claim 1 wherein the protein composition comprises greater than 46.5% glycine amino acids.

6. The protein composition of claim 5 wherein the protein composition comprises greater than 48% glycine amino acids.

7. The protein composition of claim 1 wherein the protein composition comprises greater than 30% alanine amino acids.

8. The protein composition of claim 7 wherein the protein composition comprises greater than 31.5% alanine amino acids.

9. The protein composition of claim 1 wherein a plurality of peptide chains in the protein composition terminate in amide (—C(═O)NH 2 ) groups.

10. The protein composition of claim 1 wherein the protein composition completely re-dissolves in water after being dried to a thin film.

11. The protein composition of claim 1 wherein the protein composition lacks beta-sheet protein structure in aqueous solution.

12. The protein composition of claim 1 wherein the protein composition maintains an optical absorbance in aqueous solution of less than 0.25 at 550 nm after at least five seconds of ultrasonication.

13. The protein composition of claim 1 in combination with water, wherein the protein composition completely dissolves in the water at a concentration of 10% w/w.

14. An ophthalmic formulation comprising water and a fibroin-derived protein composition, wherein:

the primary amino acid sequences of the fibroin-derived protein composition differ from native fibroin by at least 6% with respect to the combined amino acid content of serine, glycine, and alanine based on the combined absolute values of the differences in the content of serine, glycine, and alanine;

cysteine disulfide bonds between the fibroin heavy and fibroin light protein chains of fibroin are reduced or eliminated;

the protein composition has a serine content that is reduced by greater than 40% compared to native fibroin protein, and the protein composition comprises between 4.5% and 7.5% serine amino acid residues;

the average molecular weight of the protein composition is less than about 60 kDa; and

the protein composition has an aqueous viscosity of less than 4 cP as a 10% w/w solution in water.

15. The ophthalmic formulation of claim 14 wherein the fibroin-derived protein composition comprises about 0.1% by weight to about 10% by weight of the ophthalmic formulation.

16. The ophthalmic formulation of claim 15 further comprising one or more of a buffering agent, a stabilizing agent, and a demulcent.

17. The ophthalmic formulation of claim 14 wherein the protein composition is soluble in water at 40% w/w without precipitation.